Isoprostanes: an overview and putative roles in pulmonary pathophysiology
about
n-3 fatty acids, γ-linolenic acid, and antioxidants in sepsisRole of oxidized lipids in pulmonary arterial hypertensionMeasured Pulmonary and Systemic Markers of Inflammation and Oxidative Stress Following Wildland Firefighter SimulationsAcute effects of summer air pollution on pulmonary function and airway inflammation in healthy young womenLong-lived ames dwarf mice are resistant to chemical stressorsPersistence of oxidant and protease burden in the airways after smoking cessation.Modulation of the oscillatory mechanics of lung tissue and the oxidative stress response induced by arginase inhibition in a chronic allergic inflammation model.E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.Role of superoxide and thromboxane receptors in acute angiotensin II-induced vasoconstriction of rabbit vessels.Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants.24-Hour ambulatory blood pressure associates inversely with prostaglandin F(2α), interleukin-6 and F(2)-isoprostane formation in a Swedish population of older men.Cord blood 8-isoprostane in the preterm infant.Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension.NADPH:quinone oxidoreductase 1 regulates host susceptibility to ozone via isoprostane generation.Traffic-related air pollutants and exhaled markers of airway inflammation and oxidative stress in New York City adolescents.Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysisLung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspectiveAn eicosanoid-centric view of atherothrombotic risk factorsIsoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.Clinical use of exhaled biomarkers in COPD.Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans.NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?Characterization of the 5' untranslated region of alpha and beta isoforms of the human thromboxane A2 receptor (TP). Differential promoter utilization by the TP isoforms.Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.Exhaled breath marker in asthma patients with gastroesophageal reflux disease.Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmaticsThe heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension.Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle.Thromboxane A(2) receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism.8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro.Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat.Effect of 8-isoprostaglandin F2alpha on the newborn rat pulmonary arterial muscle and endothelium.Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane.Effects of chronic L-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation.Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function.Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products.
P2860
Q27693887-1C404791-42C0-4F2B-8DD2-771408AF3661Q28078566-35027A3A-14BC-4A91-A887-DCAA933C31D0Q28391773-697C30C4-07D3-461A-8909-85A856040897Q28656513-81955FC7-5EC0-4814-AED8-E7B618EC5809Q30497373-061BD4C2-7C4C-4227-BC5B-A71C2956439BQ33453893-B70B0B9E-CED5-45C5-97B9-84E2A3B3BC2FQ34943233-C70B22B6-BB16-457B-BA51-0D128F35EFB0Q35046151-DFD7E2BA-E1F1-4655-98FF-599431DF5B59Q35056975-CCBC8ECC-18A9-4737-A53C-A8B28CC35573Q35381595-D2D65337-9470-451A-BF00-CD27890356C4Q35929612-175C0B3F-6DBC-47C2-9344-6681E20CE7C3Q36049339-DF5FC22B-09B4-472A-B40A-017A37665FE7Q36202749-88BB07C2-0658-494E-8681-D1F96CAF93D7Q36620730-2E978EB2-24EB-41C4-B880-C38F43702CDFQ36625382-FDC0599B-0BE0-4912-A9D6-D212FCBDAA97Q36650599-F409D2E7-AF33-4617-805C-6CCB114DEF2CQ36787248-C31AC204-DC5F-4659-912C-77102542602AQ36887208-103EA916-E972-471F-BC76-CEC1CF5D2CDFQ36952174-A354EB54-022D-4563-A8B4-919B3834B659Q36970130-6E6DA4DA-E484-4E0E-8569-C8EEF162DF19Q37082558-6FBAC3B3-5045-4651-9A91-A5B925F39460Q37115894-E62ADA51-45AA-4023-919A-3AEABE1CE13DQ37241608-6184B59B-F881-464A-AAE5-706C67B1A34CQ37406398-77320FDD-8A15-4936-BF0D-C86214BC1750Q37725138-28D246D7-F80C-4302-84B3-1F3301C749ADQ40710557-57ADA2E1-4779-49D5-8221-2066318518FFQ41764778-7DF79F2D-059F-46BF-8822-76E8C0C6383EQ42027014-6CF5A155-ACBA-444C-B664-5756B29712E6Q42746357-119E289C-8008-4F1A-A11E-EA23ECC48538Q43253217-4BDFF365-428A-475B-8DE4-3CA363D2FFCAQ43263211-020E29A7-6F03-45CB-87A0-1D2F7857C6C3Q44064944-816DFF0E-18CA-4861-B5BB-C2F3193E090BQ44157479-44D65911-874D-45A0-AE40-743D751AEA73Q44299854-BC898A0E-E4B2-48FF-B586-9C11A955C957Q44511135-FDFA7A21-AE6E-421D-9D5A-CDD757FD9B11Q44622897-9F63712C-7271-4D83-81A8-3D25B55755C3Q46579185-B9C8ADFA-E556-4C04-9451-D6AF3AC5399CQ46847435-49DD1155-2709-41ED-9138-8D9BFA617F7EQ48672458-6390DA07-D060-449A-9AA3-06B49990D71CQ49346082-37154B9C-F52F-4C83-A20F-DEF76DACEE7C
P2860
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
description
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Juni 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 2001)
@en
vedecký článok (publikovaný 2001-06)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001-06)
@nl
наукова стаття, опублікована в червні 2001
@uk
مقالة علمية (نشرت في يونيو 2001)
@ar
name
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@ast
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@en
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@nl
type
label
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@ast
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@en
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@nl
prefLabel
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@ast
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@en
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@nl
P1476
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
@en
P2093
L J Janssen
P304
P356
10.1152/AJPLUNG.2001.280.6.L1067
P407
P577
2001-06-01T00:00:00Z